November 08, 2022 at 8:51 am

Aspira Women’s Health Broadens Distribution Reach with BioReference Collaboration

Aspira Bio-analytic women’s health company, Aspira Women’s Health (Nasdaq: AWH), will co-market its ovarian cancer detection test with BioReference®, an OPKO Health company, one of the largest full service specialty laboratories in the United States. Under terms of the agreement, Aspira and BioReference sales teams will collaborate to sell Ova1Plus to gynecologists and other women’s… [Read More]
November 07, 2022 at 10:43 pm

Bluebird Bio (BLUE) Rises 11% Despite Missing Estimates

Bluebird Bio (BLUE) rose 11% for the day, despite posting a Q3 loss and missing revenue estimates. BLUE came out with a quarterly loss of $0.92 per share, while also missing revenue estimates. A few of the main highlights from the press release are: The commercial launch of ZYNTEGLO is expected in Q4 ’22 Chris… [Read More]
November 03, 2022 at 10:36 pm

Vapotherm (VAPO) Plunges 40% On Disappointing Earnings

Vapotherm (VAPO) fell 40% today, shortly after announcing disappointing Q3 FY’22 earnings. Total revenue was $13.5 million, which is down 65% from the same period last year and missed the consensus estimate of $16.54 million. VAPO also posted a wider EPS loss than expected. The Company is currently evaluation various capital-raising ventures while continuing its… [Read More]
November 03, 2022 at 3:01 pm

Lexaria Advances Human Nicotine Study with IRB Approval; Dosing to Commence Imminently

 Global innovator in drug delivery, Lexaria Bioscience (Nasdaq: LEXX) has received Independent Board Review approval for its human nicotine study. The study will compare the company’s DehydraTECH-nicotine pouch performance to existing leading brands ON! and Zyn. The oral nicotine pouch category is one of the fastest growing segments of the nicotine industry. The global oral… [Read More]
November 03, 2022 at 2:55 pm

Accuray Partners with GE Healthcare to Advance Precision Radiation Therapy

Radiation therapy innovator, Accuray Incorporated (Nasdaq: ARAY), will collaborate with GE Healthcare to improve diagnosis and treatment across the spectrum of cancer care. The partnership will bring together GE Healthcare’s precision diagnostic tools and Accuray’s innovative radiation therapy delivery capabilities, advancing the practice of radiation therapy and helping deliver personalized care to patients diagnosed with… [Read More]
November 02, 2022 at 9:40 pm

Arcturus Therapeutics (ARCT) Jumps 19% After Collaboration With CSL For mRNA-Based Vaccines

Arcturus (ARCT) Therapeutics jumped 19% today, despite the overall market downturn. The gains come after announcing a collaboration with CSL for mRNA-based vaccines. Under the terms of the agreement, Arcturus will provide CSL Seqirus with a license to their self-amplifying mRNA technology to support the research, development, manufacture, and commercialization of vaccines for SARS-CoV-2 (COVID-19),… [Read More]
November 02, 2022 at 4:42 pm

Stocks making the biggest moves midday: Tupperware, Airbnb, Paramount, Estee Lauder and more

An employee of Tupperware Brands Corporation is at work on the production line at the group’s plant in Joue-les-Tours, centre France, on the day of its 40th anniversary. AFP PHOTO / JEAN-FRANCOIS MONIER (Photo credit should read JEAN-FRANCOIS MONIER/AFP/Getty Images) Jean-Francois Monier | AFP | Getty Images Tanaya Macheel@TANAYAMAC Check out the companies making headlines… [Read More]
October 27, 2022 at 8:55 pm

Sunnova (NOVA) Rises 10% Shortly After Reporting Q3 2022 Financial Results

Sunnova Energy (NOVA) rose 10% today, the day after reporting their Q3 2022 financial results. Some highlights from their press release can be found below. Added 21,800 customers in the third quarter of 2022, bringing total customer count to 246,600 as of September 30, 2022; Reinforced liquidity through a convertible debt raise, satisfying our projected… [Read More]
October 27, 2022 at 3:46 pm

Success of Lexaria’s Human Clinical Hypertension Study Sparks 19% Increase in Premarket Stock Price

Company achieves major milestone with potential to address $96bn market Lexaria Bioscience Corp. (Nasdaq:LEXX), a global innovator in drug delivery platforms, today shared the news of its successful human clinical study HYPER-H21-4 and the market responded: The company’s premarket stock price rose a notable 19 percent. With exceptional safety and tolerability results, the recent study showed… [Read More]
October 26, 2022 at 10:07 pm

GreenPower (GP) Soars 23% as Their All-Electric School Busses are Eligible for Purchase Under EPA Announcement

GreenPower Motor Company (GP) rose 23% today as they announced their all-electric school buses BEAST and Nano BEAST are eligible for purchase under today’s EPA announcement. According to the announcement, the Type D GreenPower BEAST all-electric school bus is eligible for $375,000 in grant funding tand the Type A all-electric GreenPower Nano BEAST is eligible… [Read More]
October 26, 2022 at 10:35 am

Positive Clinical Data for Pulse Biosciences

Bioelectric medicine company, Pulse Biosciences (Nasdaq: PLSE) has announced positive clinical data from an FDA approved Investigational Device Exempt treat and resect study on the use of its Nano-Pulse Stimulation™ (NPS) technology for low-risk basal cell carcinoma lesions. The company presented the data at the 2022 American Society for Dermatologic Surgery Annual Meeting this month…. [Read More]